The N-Terminal Residues 43 to 60 Form the Interface for Dopamine Mediated α-Synuclein Dimerisation

Elucidating the Aggregation Number of Dopamine-Induced α-Synuclein Oligomeric Assemblies

(2014) Niels Zijlstra et al.   BIOPHYSICAL JOURNAL

Protective and toxic roles of dopamine in Parkinson's disease

(2014) Juan Segura-Aguilar et al.   JOURNAL OF NEUROCHEMISTRY

Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties

(2014) Matthew S. Planchard et al.   PROTEIN SCIENCE

The interplay between lipids and dopamine on α-synuclein oligomerization and membrane binding

(2013) Chi L. L. Pham et al.   BIOSCIENCE REPORTS

Oxidative and nitrative alpha-synuclein modifications and proteostatic stress: implications for disease mechanisms and interventions in synucleinopathies

(2013) Stefan Schildknecht et al.   JOURNAL OF NEUROCHEMISTRY

Binding of Dopamine to Alpha-Synuclein is Mediated by Specific Conformational States

(2013) Eva Illes-Toth et al.   JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY

Modulation of human α-synuclein aggregation by a combined effect of calcium and dopamine

(2013) Manish Kumar Jain et al.   NEUROBIOLOGY OF DISEASE

Guanidine hydrochloride denaturation of dopamine-induced α-synuclein oligomers: A small-angle X-ray scattering study

(2013) Chi L. L. Pham et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Lipid Peroxidation Product 4-Hydroxy-2-Nonenal Promotes Seeding-Capable Oligomer Formation and Cell-to-Cell Transfer of α-Synuclein

(2012) Eun-Jin Bae et al.   ANTIOXIDANTS & REDOX SIGNALING

Advances in ion mobility spectrometry–mass spectrometry reveal key insights into amyloid assembly

(2012) L.A. Woods et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

α-Synuclein misfolding and Parkinson's disease

(2011) Leonid Breydo et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Disordered proteins studied by chemical shifts

(2011) Magnus Kjaergaard et al.   PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY

How useful is ion mobility mass spectrometry for structural biology? The relationship between protein crystal structures and their collision cross sections in the gas phase

(2010) Ewa Jurneczko et al.   ANALYST

Dopamine quinones interact with α-synuclein to form unstructured adducts

(2010) Marco Bisaglia et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The structure of dopamine induced α-synuclein oligomers

(2010) Agata Rekas et al.   EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS

Dopamine facilitates α-synuclein oligomerization in human neuroblastoma SH-SY5Y cells

(2009) Kentaro Yamakawa et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation

(2009) Su Ling Leong et al.   FREE RADICAL BIOLOGY AND MEDICINE

Dopamine and the Dopamine Oxidation Product 5,6-Dihydroxylindole Promote Distinct On-Pathway and Off-Pathway Aggregation of α-Synuclein in a pH-Dependent Manner

(2009) Chi L.L. Pham et al.   JOURNAL OF MOLECULAR BIOLOGY

Characterization of Inhibitor-Bound α-Synuclein Dimer: Role of α-Synuclein N-Terminal Region in Dimerization and Inhibitor Binding

(2009) Yoshiki Yamaguchi et al.   JOURNAL OF MOLECULAR BIOLOGY

Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease

(2009) Taku Hatano et al.   JOURNAL OF NEUROCHEMISTRY

Endogenous catecholamine enhances the dysfunction of unfolded protein response and α-synuclein oligomerization in PC12 cells overexpressing human α-synuclein

(2009) Satoru Ito et al.   NEUROSCIENCE RESEARCH

Sequence determinants regulating fibrillation of human α-synuclein

(2008) Hyun-Jung Koo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region

(2008) Fernando E. Herrera et al.   PLoS One